Swain R A, Kaplan B, Montgomery E
West Virginia University-Charleston Division, USA.
Postgrad Med. 1996 Nov;100(5):181-2, 185, 188-93. doi: 10.3810/pgm.1996.11.116.
Iron deficiency anemia is a common problem encountered in primary care practice. Once the diagnosis is confirmed and the possible causes are identified, replacement of iron stores is indicated. Most patients respond favorably to oral iron preparations. However, therapy with intravenous iron dextran (InFeD) may be warranted in some cases. Side effects, which are usually mild, occur in 25% of patients. Test doses of undiluted iron dextran occasionally elicit anaphylactic reactions. However, affected patients still may be successfully treated intravenously with the use of prophylactic antihistamines, corticosteroids, and histamine2 blockers. Treatment of iron deficiency anemia almost always brings symptomatic improvement.
缺铁性贫血是基层医疗实践中常见的问题。一旦确诊并确定了可能的病因,就需要补充铁储备。大多数患者对口服铁制剂反应良好。然而,在某些情况下可能需要使用右旋糖酐铁静脉注射液(InFeD)进行治疗。副作用通常较轻,25%的患者会出现。未稀释的右旋糖酐铁试验剂量偶尔会引发过敏反应。不过,使用预防性抗组胺药、皮质类固醇和组胺2受体阻滞剂,受影响的患者仍可成功接受静脉治疗。缺铁性贫血的治疗几乎总能带来症状改善。